Results 21 to 30 of about 280,167 (140)

Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects. [PDF]

open access: hybridContraception, 2018
In 2015, private healthcare providers in Nigeria introduced DMPA-SC (depot medroxyprogesterone acetate administered subcutaneously) into the method mix. We aimed to [1] examine the sociodemographic predictors of continued DMPA-SC use after 3 months, and [2] characterize the additional influences of contraceptive counseling quality and experiences of ...
Liu J, Shen J, Diamond-Smith N.
europepmc   +8 more sources

Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey [PDF]

open access: yesFrontiers in Global Women's Health
IntroductionThis study aimed to identify the determinants that influence the use of DMPA-SC/Sayana Press among women who use modern contraceptive methods in Burkina Faso.MethodsThis study used secondary data obtained from the 2021 Burkina Faso ...
Aristide Romaric Bado
doaj   +3 more sources

Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers. [PDF]

open access: hybridContraception, 2018
To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC.This article compares results from interviews with DMPA-SC providers in two separate pilot studies: 1) 53 medical and nursing ...
Hernandez JH   +5 more
europepmc   +6 more sources

Setbacks in the road to self-injection: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria [PDF]

open access: yesFrontiers in Global Women's Health
This mixed-methods study describes perspectives from health providers and simulated clients on initiation and continuation of DMPA-SC for self-injection in Nigeria.
Madeline Griffith   +9 more
doaj   +3 more sources

Self-injected Depot–Medroxyprogesterone Acetate Subcutaneous (DMPA-SC) Uptake in Nigeria: A Paradigm Shift [PDF]

open access: diamondTEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH, 2021
Self-injection of DMPA-SC method is one of the Government of Nigeria’s (GON) national family planning goals to address the unmet need for contraception.
Kehinde Osinowo
semanticscholar   +3 more sources

Lessons learned from a public sector community-based distribution program for scaling up DMPA-SC contraceptive services in Nigeria

open access: goldGates Open Research, 2019
Background: From August 2016 to December 2017, the United Nations Population Fund (UNFPA) in Nigeria, through three implementing partners, scaled up the public sector delivery of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana ...
Eric Schatzkin   +5 more
semanticscholar   +3 more sources

Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial [PDF]

open access: hybridContraception, 2018
To describe women's experiences with subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to inform scale-up of self-administered DMPA-SC.We conducted a 12-month randomized controlled trial in Malawi to measure DMPA-SC continuation rates. A total of 731 women presenting at six Ministry of Health clinics or to community health workers (CHWs) in ...
Holly M. Burke   +7 more
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy